Literature DB >> 2381167

Computer assisted efficiency testing of different sampling methods for selective nuclear graphic tablet morphometry.

J C Fleege1, P J van Diest, J P Baak.   

Abstract

Selective nuclear graphic tablet morphometry is widely employed as a useful tool in quantitative pathological assessments. The value of such a measuring system is strongly determined by the sampling rule that has to ensure high measurement precision with minimal effort. Therefore, the efficiency of four different random sampling methods (i.e., the pure "random," "zone," "at convenience," and "raster" methods) was tested by means of computer simulated sampling in nuclear study populations derived from histological sections of three endometrial hyperplasias and nine endometrial carcinomas. The 12 nuclear study populations each consisted of 1000 intact nuclei that were systematically measured within demarcated measurement fields by an experienced morphometrist. To attain an arbitrarily chosen measurement precision of 2.5% the computer simulations showed that the random and the raster methods required much smaller sample sizes than the zone and at convenience methods. By using the random and raster methods for assessment of the nuclear area, a maximal sample size of 200 nuclei was necessary, whereas the zone and at convenience methods mostly required more than 200 nuclei. For features such as the perimeter, longest axis, shortest axis, and two shape factors (form-PE and roundness), and the same level of precision, the sample size could be considerably smaller. The differences in efficiency can be explained by the existence of clustering and gradients in the value distribution of a nuclear feature within the measurement field. In contrast to the zone and at convenience methods, the random and raster methods sample nuclei from the entire measurement field and thus do not limit sampling to only a few larger areas within that field. Consequently, the latter two sampling methods cope better with an uneven spatial distribution in the magnitude of a nuclear feature and can thereby help to keep the measurement reproducibility high.

Entities:  

Mesh:

Year:  1990        PMID: 2381167

Source DB:  PubMed          Journal:  Lab Invest        ISSN: 0023-6837            Impact factor:   5.662


  8 in total

1.  Improved objectivity of grading of T(A,1) transitional cell carcinomas of the urinary bladder by quantitative nuclear and proliferation related features.

Authors:  M G Bol; J P Baak; P C de Bruin; S Rep; W Marx; S Bos; O Kisman
Journal:  J Clin Pathol       Date:  2001-11       Impact factor: 3.411

2.  Prognostic value of proliferative activity in lymph node metastases of patients with breast cancer.

Authors:  P J van Diest; E Matze-Cok; J P Baak
Journal:  J Clin Pathol       Date:  1991-05       Impact factor: 3.411

3.  Cyclin D1 expression in invasive breast cancer. Correlations and prognostic value.

Authors:  P J van Diest; R J Michalides; L Jannink; P van der Valk; H L Peterse; J S de Jong; C J Meijer; J P Baak
Journal:  Am J Pathol       Date:  1997-02       Impact factor: 4.307

4.  A scoring system for immunohistochemical staining: consensus report of the task force for basic research of the EORTC-GCCG. European Organization for Research and Treatment of Cancer-Gynaecological Cancer Cooperative Group.

Authors:  P J van Diest; P van Dam; S C Henzen-Logmans; E Berns; M E van der Burg; J Green; I Vergote
Journal:  J Clin Pathol       Date:  1997-10       Impact factor: 3.411

5.  A cytotoxic phenotype does not predict clinical outcome in anaplastic large cell lymphomas.

Authors:  D F Dukers; R L ten Berge; J J Oudejans; K Pulford; D Hayes; J F Miseré; G J Ossenkoppele; L H Jaspars; R Willemze; C J Meijer
Journal:  J Clin Pathol       Date:  1999-02       Impact factor: 3.411

6.  Counting of apoptotic cells: a methodological study in invasive breast cancer.

Authors:  H A van de Schepop; J S de Jong; P J van Diest; J P Baak
Journal:  Clin Mol Pathol       Date:  1996-08

7.  At convenience and systematic random sampling: effects on the prognostic value of nuclear area assessments in breast cancer patients.

Authors:  I Jannink; J N Bennen; J Blaauw; P J van Diest; J P Baak
Journal:  Breast Cancer Res Treat       Date:  1995       Impact factor: 4.872

8.  Nuclear morphometric features in benign breast tissue and risk of subsequent breast cancer.

Authors:  Yan Cui; Esther A Koop; Paul J van Diest; Rita A Kandel; Thomas E Rohan
Journal:  Breast Cancer Res Treat       Date:  2006-10-24       Impact factor: 4.872

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.